NATALIE LANE: Open Payments
NPI 1508269663 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,016 in 174 payments from 22 companies in 2025. Trend: 2023 $2,200 · 2024 $2,673 · 2025 $3,016
Food & beverage: $3,016
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 56 | $619 |
| E.R. Squibb & Sons, L.L.C. | 16 | $373 |
| UCB, Inc. | 18 | $341 |
| AstraZeneca Pharmaceuticals LP | 14 | $339 |
| ABBVIE INC. | 17 | $291 |
| Novartis Pharmaceuticals Corporation | 10 | $227 |
| GlaxoSmithKline, LLC. | 8 | $179 |
| Janssen Biotech, Inc. | 8 | $168 |
| PFIZER INC. | 6 | $96 |
| Aurinia Pharma U.S., Inc. | 3 | $63 |
Products named: ORENCIA, Bimzelx, SAPHNELO, KRYSTEXXA, RINVOQ, COSENTYX, BENLYSTA, TREMFYA.
Industry payments across IN — which companies pay providers there.
